• HOME
  • TFOS DEWS II REPORT
  • SPONSORS
logo
  • HOME
  • TFOS DEWS II REPORT
  • SPONSORS
  • HOME
  • TFOS DEWS II REPORT
  • SPONSORS
    • ALCON
    • NOVARTIS
    • SHIRE
    • ALLERGAN
    • BAUSCH + LOMB
    • AKORN
    • COOPER VISION
    • DOMPÈ
    • HORUS
    • LUBRIS
    • OCULEVE
    • SUN PHARMA
    • TEAR LAB
    • THEA
    • SIFI
    • JOHNSON & JOHNSON
    • ZEISS
    • QUINT HEALTH
    • SCOPE
    • SENJU
  • Introduction
  • Definition and classification
  • Sex, Gender, Hormone
  • Epidemiology Report
  • Tear Film
  • Pain and Sensation
  • Pathophysiology
  • Iatrogenic Dry Eye
  • Diagnostic Methodology
  • Management and Therapy
  • Clinical Trial Design

TFOS DEWS II - Introduction

The purpose of this report is to review our understanding of the pathophysiology of DED, highlighting those advances that have occurred since the TFOS DEWS report [1]. Our general thesis is that DED is initiated by desiccating stress and perpetuated by a Vicious Circle of ocular surface inflammation.
The raison d'etre of the eye is sight and the precorneal tear film and the cornea provide the first refractive element of the eye that focuses an image of the visual world upon the retina. To maintain optical quality, the tear film must be constantly replenished by blinking and tear secretion. Without this, the tear film would destabilise and the surface of the eye would be exposed to damaging desiccation. Various mechanisms are in place to achieve homeostasis.
Tear Film & Ocular Surface Society Boston, MA 02113 USA - © All Rights Reserved.
twitter - youtube - blog - linked in - download the TFOS app on the Appstore - download the TFOS App for Android
Questo sito utilizza cookie di profilazione propri e di siti terzi. Se vuoi saperne di più consula la cookie policy. Chiudendo questo banner acconsenti all'uso dei cookie. Grazie
Ok
Leggi di più